Taipei Exchange - Delayed Quote TWD

Advagene Biopharma Co., Ltd. (6709.TWO)

17.30
0.00
(0.00%)
At close: 2:25:59 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
70,823
70,823
93,336
119,810
94,426
Operating Income
-70,823
-70,823
-93,336
-119,810
-94,426
Net Non Operating Interest Income Expense
1,547
1,547
981
1,231
1,400
Pretax Income
-69,421
-69,421
-92,110
-118,377
-92,686
Net Income Common Stockholders
-69,421
-69,421
-92,110
-118,377
-92,686
Diluted NI Available to Com Stockholders
-69,421
-69,421
-92,110
-118,377
-92,686
Basic EPS
-1.27
--
-1.83
-2.40
-1.88
Diluted EPS
-1.27
--
-1.83
-2.40
-1.88
Basic Average Shares
54,662.21
--
50,333.33
49,323.75
49,176.99
Diluted Average Shares
59,380
--
50,333.33
49,323.75
49,176.99
Total Expenses
70,823
70,823
93,336
119,810
94,426
Net Income from Continuing & Discontinued Operation
-69,421
-69,421
-92,110
-118,377
-92,686
Normalized Income
-69,421
-69,421
-92,110
-118,377
-92,686
Interest Income
1,698
1,698
1,017
1,312
1,527
Interest Expense
151
151
36
81
127
Net Interest Income
1,547
1,547
981
1,231
1,400
EBIT
-69,270
-69,270
-92,074
-118,296
-92,559
EBITDA
-67,090
-67,090
-80,072
-106,694
-84,834
Reconciled Depreciation
2,180
2,180
12,002
11,602
7,725
Net Income from Continuing Operation Net Minority Interest
-69,421
-69,421
-92,110
-118,377
-92,686
Normalized EBITDA
-67,090
-67,090
-80,072
-106,694
-84,834
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/29/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers